{"id":109324,"date":"2021-05-31T09:24:04","date_gmt":"2021-05-31T09:24:04","guid":{"rendered":"https:\/\/www.healthbenefitstimes.com\/glossary\/?p=109324"},"modified":"2021-05-31T09:24:04","modified_gmt":"2021-05-31T09:24:04","slug":"spielmeyer-vogt-disease","status":"publish","type":"post","link":"https:\/\/www.healthbenefitstimes.com\/glossary\/spielmeyer-vogt-disease\/","title":{"rendered":"Spielmeyer Vogt disease"},"content":{"rendered":"<p>Spielmeyer-Vogt disease is the juvenile form of a group of progressive neurological diseases known as neuronal ceroid lipofuscinoses (NCL). Also known as Speilmeyer-Vogt- Sjogren-Batten disease or Batten disease after a British pediatrician who first described it in 1903. Spielmeyer-Vogt disease is an autosomal recessive disorder. Therefore, when both parents carry the gene, their children have a 25% chance of developing the disease. Symptoms of Spielmeyer- Vogt disease are linked to the buildup of lipopigments in the body\u2019s tissues. These lipopigments are made up of fats and proteins and build up in the cells of the brain and eyes as well as the skin, muscles, and other tissues.<\/p>\n<hr \/>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Spielmeyer-Vogt disease is the juvenile form of a group of progressive neurological diseases known as neuronal ceroid lipofuscinoses (NCL). Also known as Speilmeyer-Vogt- Sjogren-Batten disease or Batten disease after a British pediatrician who first described it in 1903. Spielmeyer-Vogt disease is an autosomal recessive disorder. Therefore, when both parents carry the gene, their children have [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[19],"tags":[],"class_list":["post-109324","post","type-post","status-publish","format-standard","hentry","category-s"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v21.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Spielmeyer Vogt disease - Definition of Spielmeyer Vogt disease<\/title>\n<meta name=\"description\" content=\"Spielmeyer-Vogt disease is the juvenile form of a group of progressive neurological diseases known as neuronal ceroid lipofuscinoses (NCL). Also known as Speilmeyer-Vogt- Sjogren-Batten disease or Batten disease after a British pediatrician who first described it in 1903. Spielmeyer-Vogt disease is an autosomal recessive disorder. Therefore, when both parents carry the gene, their children have a 25% chance of developing the disease. Symptoms of Spielmeyer- Vogt disease are linked to the buildup of lipopigments in the body\u2019s tissues. These lipopigments are made up of fats and proteins and build up in the cells of the brain and eyes as well as the skin, muscles, and other tissues.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.healthbenefitstimes.com\/glossary\/spielmeyer-vogt-disease\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Spielmeyer Vogt disease - Definition of Spielmeyer Vogt disease\" \/>\n<meta property=\"og:description\" content=\"Spielmeyer-Vogt disease is the juvenile form of a group of progressive neurological diseases known as neuronal ceroid lipofuscinoses (NCL). Also known as Speilmeyer-Vogt- Sjogren-Batten disease or Batten disease after a British pediatrician who first described it in 1903. Spielmeyer-Vogt disease is an autosomal recessive disorder. Therefore, when both parents carry the gene, their children have a 25% chance of developing the disease. Symptoms of Spielmeyer- Vogt disease are linked to the buildup of lipopigments in the body\u2019s tissues. These lipopigments are made up of fats and proteins and build up in the cells of the brain and eyes as well as the skin, muscles, and other tissues.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.healthbenefitstimes.com\/glossary\/spielmeyer-vogt-disease\/\" \/>\n<meta property=\"og:site_name\" content=\"Glossary\" \/>\n<meta property=\"article:published_time\" content=\"2021-05-31T09:24:04+00:00\" \/>\n<meta name=\"author\" content=\"Glossary\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Glossary\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/spielmeyer-vogt-disease\/\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/spielmeyer-vogt-disease\/\",\"name\":\"Spielmeyer Vogt disease - Definition of Spielmeyer Vogt disease\",\"isPartOf\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#website\"},\"datePublished\":\"2021-05-31T09:24:04+00:00\",\"dateModified\":\"2021-05-31T09:24:04+00:00\",\"author\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5\"},\"description\":\"Spielmeyer-Vogt disease is the juvenile form of a group of progressive neurological diseases known as neuronal ceroid lipofuscinoses (NCL). Also known as Speilmeyer-Vogt- Sjogren-Batten disease or Batten disease after a British pediatrician who first described it in 1903. Spielmeyer-Vogt disease is an autosomal recessive disorder. Therefore, when both parents carry the gene, their children have a 25% chance of developing the disease. Symptoms of Spielmeyer- Vogt disease are linked to the buildup of lipopigments in the body\u2019s tissues. These lipopigments are made up of fats and proteins and build up in the cells of the brain and eyes as well as the skin, muscles, and other tissues.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/spielmeyer-vogt-disease\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.healthbenefitstimes.com\/glossary\/spielmeyer-vogt-disease\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/spielmeyer-vogt-disease\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Spielmeyer Vogt disease\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#website\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/\",\"name\":\"Glossary\",\"description\":\"Difinitions\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5\",\"name\":\"Glossary\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/author\/adminglossary\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Spielmeyer Vogt disease - Definition of Spielmeyer Vogt disease","description":"Spielmeyer-Vogt disease is the juvenile form of a group of progressive neurological diseases known as neuronal ceroid lipofuscinoses (NCL). Also known as Speilmeyer-Vogt- Sjogren-Batten disease or Batten disease after a British pediatrician who first described it in 1903. Spielmeyer-Vogt disease is an autosomal recessive disorder. Therefore, when both parents carry the gene, their children have a 25% chance of developing the disease. Symptoms of Spielmeyer- Vogt disease are linked to the buildup of lipopigments in the body\u2019s tissues. These lipopigments are made up of fats and proteins and build up in the cells of the brain and eyes as well as the skin, muscles, and other tissues.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.healthbenefitstimes.com\/glossary\/spielmeyer-vogt-disease\/","og_locale":"en_US","og_type":"article","og_title":"Spielmeyer Vogt disease - Definition of Spielmeyer Vogt disease","og_description":"Spielmeyer-Vogt disease is the juvenile form of a group of progressive neurological diseases known as neuronal ceroid lipofuscinoses (NCL). Also known as Speilmeyer-Vogt- Sjogren-Batten disease or Batten disease after a British pediatrician who first described it in 1903. Spielmeyer-Vogt disease is an autosomal recessive disorder. Therefore, when both parents carry the gene, their children have a 25% chance of developing the disease. Symptoms of Spielmeyer- Vogt disease are linked to the buildup of lipopigments in the body\u2019s tissues. These lipopigments are made up of fats and proteins and build up in the cells of the brain and eyes as well as the skin, muscles, and other tissues.","og_url":"https:\/\/www.healthbenefitstimes.com\/glossary\/spielmeyer-vogt-disease\/","og_site_name":"Glossary","article_published_time":"2021-05-31T09:24:04+00:00","author":"Glossary","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Glossary","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/spielmeyer-vogt-disease\/","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/spielmeyer-vogt-disease\/","name":"Spielmeyer Vogt disease - Definition of Spielmeyer Vogt disease","isPartOf":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#website"},"datePublished":"2021-05-31T09:24:04+00:00","dateModified":"2021-05-31T09:24:04+00:00","author":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5"},"description":"Spielmeyer-Vogt disease is the juvenile form of a group of progressive neurological diseases known as neuronal ceroid lipofuscinoses (NCL). Also known as Speilmeyer-Vogt- Sjogren-Batten disease or Batten disease after a British pediatrician who first described it in 1903. Spielmeyer-Vogt disease is an autosomal recessive disorder. Therefore, when both parents carry the gene, their children have a 25% chance of developing the disease. Symptoms of Spielmeyer- Vogt disease are linked to the buildup of lipopigments in the body\u2019s tissues. These lipopigments are made up of fats and proteins and build up in the cells of the brain and eyes as well as the skin, muscles, and other tissues.","breadcrumb":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/spielmeyer-vogt-disease\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.healthbenefitstimes.com\/glossary\/spielmeyer-vogt-disease\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/spielmeyer-vogt-disease\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.healthbenefitstimes.com\/glossary\/"},{"@type":"ListItem","position":2,"name":"Spielmeyer Vogt disease"}]},{"@type":"WebSite","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#website","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/","name":"Glossary","description":"Difinitions","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.healthbenefitstimes.com\/glossary\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5","name":"Glossary","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/author\/adminglossary\/"}]}},"_links":{"self":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/109324","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/comments?post=109324"}],"version-history":[{"count":1,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/109324\/revisions"}],"predecessor-version":[{"id":109325,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/109324\/revisions\/109325"}],"wp:attachment":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/media?parent=109324"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/categories?post=109324"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/tags?post=109324"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}